Investments
YM Biosciences, Inc.
AMEX: YMI
Product development company focused on advancing cancer products along the regulatory and clinical pathways towards commercial approval
Sector: Biopharmaceuticals, Healthcare
Company Status: Public
Investment Status: Historical
Associated Team Members:
James Barrett, PhD